Literature DB >> 20661136

The rapid effects of estrogen: a mini-review.

Sonali Lokuge1, Benicio N Frey, Jane A Foster, Claudio N Soares, Meir Steiner.   

Abstract

Estrogen is regulated through two intracellular receptors, estrogen receptor alpha and estrogen receptor beta, through a classic nuclear-initiated response. Recently, estrogen has also been shown to act more rapidly and it is proposed that these fast effects may be the consequence of membrane localized estrogen receptors that act through the second messengers. Although the identification of these receptors remains to be elucidated, the possible role that they play in female-specific mood disorders is of particular interest, especially in times of major hormonal fluctuation. The purpose of this mini-review is to outline the recent literature regarding the rapid effects of estrogen, to explore the intracellular signaling pathways that may be involved in this regulation as well as the connection between estrogen and serotonin neurotransmission and finally, to look into the antidepressant role that estrogen may have, with particular emphasis on female-specific mood disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20661136     DOI: 10.1097/FBP.0b013e32833da5c3

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  17 in total

1.  Is there a role for estrogen in treating depression during menopause?

Authors:  Claudio N Soares; Benicio N Frey
Journal:  J Psychiatry Neurosci       Date:  2010-11       Impact factor: 6.186

Review 2.  Insights into rapid modulation of neuroplasticity by brain estrogens.

Authors:  Deepak P Srivastava; Kevin M Woolfrey; Peter Penzes
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

3.  Conjugated equine estrogen, with medroxyprogesterone acetate, enhances formation of 5alpha-reduced progestogens and reduces anxiety-like behavior of middle-aged rats.

Authors:  Cheryl A Frye; Alicia A Walf; Jason J Paris
Journal:  Behav Pharmacol       Date:  2010-09       Impact factor: 2.293

Review 4.  Depression in peri- and postmenopausal women: prevalence, pathophysiology and pharmacological management.

Authors:  Claudio N Soares
Journal:  Drugs Aging       Date:  2013-09       Impact factor: 3.923

Review 5.  Role of estrogen treatment in the management of schizophrenia.

Authors:  Jayashri Kulkarni; Emmy Gavrilidis; Roisin Worsley; Emily Hayes
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

6.  Association study of the estrogen receptor gene ESR1 with postpartum depression--a pilot study.

Authors:  Julia K Pinsonneault; Danielle Sullivan; Wolfgang Sadee; Claudio N Soares; Elizabeth Hampson; Meir Steiner
Journal:  Arch Womens Ment Health       Date:  2013-08-07       Impact factor: 3.633

7.  Luteal phase and symptom-onset dosing of SSRIs/SNRIs in the treatment of premenstrual dysphoria: clinical evidence and rationale.

Authors:  Meir Steiner; Tina Li
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

8.  Can depression be a menopause-associated risk?

Authors:  Claudio N Soares
Journal:  BMC Med       Date:  2010-12-01       Impact factor: 8.775

9.  Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic scientists.

Authors:  Virginia M Miller; Jay R Kaplan; Nicholas J Schork; Pamela Ouyang; Sarah L Berga; Nanette K Wenger; Leslee J Shaw; R Clinton Webb; Monica Mallampalli; Meir Steiner; Doris A Taylor; C Noel Bairey Merz; Jane F Reckelhoff
Journal:  Biol Sex Differ       Date:  2011-12-12       Impact factor: 5.027

10.  The role of oestrogen and other hormones in the pathophysiology and treatment of schizophrenia.

Authors:  Emily Hayes; Emorfia Gavrilidis; Jayashri Kulkarni
Journal:  Schizophr Res Treatment       Date:  2012-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.